{"id":"NCT03088137","sponsor":"IVFarma LLC","briefTitle":"Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment","officialTitle":"Multicentre Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-02-08","primaryCompletion":"2018-08-17","completion":"2018-08-17","firstPosted":"2017-03-23","resultsPosted":"2019-06-06","lastUpdate":"2022-04-01"},"enrollment":118,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Infertility, Female"],"interventions":[{"type":"DRUG","name":"Follitropin alfa (Gonal-f)","otherNames":[]},{"type":"DRUG","name":"Follitropin alfa (Primapur)","otherNames":[]}],"arms":[{"label":"Primapur (Follitropin alfa)","type":"EXPERIMENTAL"},{"label":"Gonal-f (Follitropin alfa)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to show equivalence with regard to the number of oocytes retrieved between follitropin alfa (pen-injectors) Primapur® and Gonal-f® in woman undergoing IVF/ICSI","primaryOutcome":{"measure":"Oocytes (Intention-to-Treat, ITT)","timeFrame":"From date of randomization up to 18 days","effectByArm":[{"arm":"Primapur (Follitropin Alfa)","deltaMin":12.16,"sd":7.28},{"arm":"Gonal-f (Follitropin Alfa)","deltaMin":11.62,"sd":6.29}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":19},"locations":{"siteCount":3,"countries":["Russia"]},"refs":{"pmids":["31400644","35222266"],"seeAlso":["https://doi.org/10.1016/j.ejogrb.2019.07.032"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":55},"commonTop":["Ovarian hyperstimulation syndrome","Lower abdominal pain","Lower abdominal pain","Abnormal vaginal bleeding","Spontaneous miscarriage"]}}